Drawing for SUNVEPZI

USPTO serial 87345934

SUNVEPZI

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
STOIDES, KATHERINE
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUNVEPZI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marilyn F. Kelly

MARILYN F. KELLY BRISTOL-MYERS SQUIBB COMPANYP.O. BOX 4000TRADEMARKS DEPT. - MAILSTOP B22-02PRINCETON, NJ 08648-4000

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodiesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 17, 2018MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Apr 17, 2018ABN5ABANDONMENT - AFTER PUBLICATION—
Apr 10, 2018EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 22, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 22, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 22, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 15, 2017ALIEASSIGNED TO LIE—
Nov 3, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 9, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 9, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 8, 2017DOCKASSIGNED TO EXAMINER—
Mar 1, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance